Title: Establishing%20Rules%20for:
1- Establishing Rules for
- Medical Device Reports (803)
- Correction and Removal Reports (806)
Presented by Cap Uldriks, FDA Daniel P. Olivier,
CCS
2Objectives
- Define regulatory reporting rules based on
established standards - Simplify regulatory reporting decision making
- Establish defensible basis to support compliance
with reporting regulations - Reduce risk of non-compliance observations
3AGENDA
- Reporting Regulations
- Evaluating Safety Risks
- Defining the Strategy
- Summary
4Reporting Regulations
521 CFR Part 803 Medical Device Reporting
- MDR reportable event means
- (1) User facilities become aware of information
that reasonably suggests a device has or may have
caused or contributed to a death or serious
injury or - (2) Manufacturers or importers become aware of
information that reasonably suggests one of their
marketed devices - (i) May have caused or contributed to a death or
serious injury, or - (ii) Has malfunctioned and that the device or a
similar device marketed by the manufacturer or
importer would be likely to cause or contribute
to a death or serious injury if the malfunction
were to recur.
6Compliance Program Guidance for 21 CFR Part
803Medical Device Reporting
- If the event is likely to cause or contribute to
death or serious injury" then the event is
reportable - The preamble offers the following guidance, i.e.,
a malfunction report is required when - 1.The chance of a death or serious injury
occurring as a result of the recurrence of the
malfunction is not remote - 2.The consequences of the malfunction affect
the device in a catastrophic manner that may lead
to a death or serious injury (Class I Recall)
721 CFR Part 806 Corrections and Removal Reporting
- Sec. 806.10 Reports of corrections and removals.
- (a) Each device manufacturer or importer shall
submit a written report to FDA of any correction
or removal of a device initiated by them - (1) To reduce a risk to health posed by the
device or - (2) To remedy a violation of the act caused by
the device which may present a risk to health
unless the information has already been provided
under Part 803 or Part 1004 or the action is
exempt from the reporting under 806.1(b).
8Compliance Program Guidance for 21 CFR Part 806
FDA Corrections and Removals Reporting
- Risk to Health - The key concept to determine
whether an event is reportable under Part 806 - Use of, or exposure to, the product may cause
temporary or medically reversible adverse health
consequences, or an outcome where the probability
of serious adverse health consequences is remote
(Class II Recall).
921 CFR Part 7.3 Recall Class Definitions
- Class I is a situation in which there is
reasonable probability that the use of, or
exposure to, a violative product will cause
serious adverse health consequences or death
(criteria for 803 reporting) - Class II is a situation in which there is
reasonable probability that the use of, or
exposure to, a violative product may cause
temporary or medically reversible adverse health
consequences or where the probability of serious
adverse health consequences is remote (criteria
for 806 reporting) - Class III is a situation in which there is
reasonable probability that the use of, or
exposure to, a violative product is not likely to
cause serious adverse health consequences
10Evaluating Safety Risk
11Risk Evaluation, Severity
- Severity - Assess the worst possible
consequence, defined by degree of injury or
illness that could occur. Severity
classification identified as follows - Major, may cause death or serious injury
- Moderate, may cause non-serious injury
- Minor, not expected to cause injury
Based on Levels of Concern defined in
Guidance for the Content of Premarket Submissions
for Software Contained in Medical Devices, Food
and Drug Administration, May 11,2005.
12MIL-STD 882D Severity Levels
- Severity Suggested mishap categories
- Catastrophic, could result in death, permanent
total disability, loss exceeding 1M - Critical, could result in permanent partial
disability, or that may result in hospitalization
of at least three people, 200k-1M loss - Marginal, could result in injury resulting in
more than one lost work day, 10K-200K loss - Negligible, could result in injury resulting in
less than one lost day, less than 10K
Standard Practice for System Safety,
MIL-STD-882D, Department of Defense, February 10,
2000, Appendix A, Table A-1, page 18
13ISO 149712000 Severity Levels
- Severity levels may be descriptive, e.g.
- Catastrophic
- Serious
- Critical
- Marginal
- Negligible
Medical device - Application of safety risk
management to medical devices, ANSI/AAMI/ISO
149712000 section E.2.2, page 32
14Consolidated Severity Levels
MIL-STD
882D ISO 149712000 FDA Guidance
Catastrophic Catastrophic Major
Serious Major Critical Critical Major Mar
ginal Marginal Moderate Negligible
Negligible Minor
15MIL-STD-882D Risk Evaluation, Probability
- Probability - Probability that a mishap will
occur during the planned life expectancy of the
system - Frequent - Likely to occur often
- (X gt 10-1)
- Probable - Will occur several times in the life
of the system. - (10-1 gtX gt10-2)
- Occasional - Likely to occur sometime in the life
of the system. (10-2 gtX gt10-3) - Remote - Unlikely but possible to occur in the
life of the system. (10-3 gtX gt10-6 ) - Improbable - So unlikely, it can be assumed
occurrence - may not be experienced
- (X lt 10-6)
Standard Practice for System Safety,
MIL-STD-882D, Department of Defense, February 10,
2000, Appendix A, Table A-2, page 19
16ISO 149712000 Risk Evaluation, Probability
- Probability - Probability estimation examines the
initiating events or circumstances and the
sequences of events that are of concern - Frequent
- Probable
- Occasional
- Remote
- Improbable
- Incredible
Medical device - Application of safety risk
management to medical devices, ANSI/AAMI/ISO
149712000 section E.2.1, page 31
17Proposed Risk Assessment Matrix for FDA Adverse
Event Reporting
Minor
Moderate Major
Frequent Probable Occasional Remote
Improbable
Note Probability level of Incredible from ISO
149712003 not included
18Defining the Strategy
19Compliance Program Guidance for 21 CFR Part
803Medical Device Reporting
- If the event is likely to cause or contribute to
death or serious injury" then the event is
reportable - The preamble offers the following guidance, i.e.,
a malfunction report is required when - 1.The chance of a death or serious injury
occurring as a result of the recurrence of the
malfunction is not remote - 2.The consequences of the malfunction affect
the device in a catastrophic manner that may lead
to a death or serious injury
20Proposed Risk Assessment Matrix for FDA Adverse
Event Reporting
Minor
Moderate Major
Frequent Probable Occasional Remote
Improbable
MDR MDR MDR
Note Probability level of Incredible from ISO
149712003 not included
21Compliance Program Guidance for 21 CFR Part 806
FDA Corrections and Removals Reporting
- Reports are NOT required IF The information has
already been reported to FDA under the MDR
regulation, 21 CFR Part 803 or under 21 CFR 1004
(Replacement of Electronic Products). - The key concept for determining when an event is
reportable is the CAR regulation's definition of
risk to health - Use of, or exposure to, the product may cause
temporary or medically reversible adverse health
consequences, or an outcome where the probability
of serious adverse health consequences is remote
(Class II Recall).
22Proposed Risk Assessment Matrix for FDA Adverse
Event Reporting
Minor
Moderate Major
Frequent Probable Occasional Remote
Improbable
MDR MDR MDR CAR NR
CAR CAR CAR NR NR
NR NR NR NR NR
NR - Not reportable CAR - Reportable under 21 CFR
Part 806 MDR - reportable under 21 CFR Part 803
23Summary
24Defining Reporting Strategy
- Reference to external standards/guidelines
provides defensibility for decision making - Established rules provide
- consistency
- use of common terminology
- facilitate training
- Established rules reduce compliance risk
25References
- Medical device - Application of safety risk
management to medical devices, ANSI/AAMI/ISO
149712000. - Guidance for the Content of Premarket Submissions
for Software Contained in Medical Devices, FDA,
Office of Device Evaluation, May 11, 2005. - Standard Practice for System Safety,
MIL-STD-882D, Department of Defense, February 10,
2000. - 21 CFR Part 7 Enforcement Policy, US Federal
Register, Food and Drug Administration.